The spike protein found in SARS-CoV-2 contains a sequence identical to a genetic code linked to a piece of a gene patented by Moderna three years before the pandemic emerged, researchers found.
QUICK FACTS:
- An international team of researchers published a study in Frontiers in Virology, finding that the furin cleavage site (FCS) of SARS-CoV-2 holds a small amount of genetic code that replicates a part of a gene the pharmaceutical company Moderna patented in 2016.
- The researchers argue that because the chance of Moderna’s sequence randomly appearing naturally is 1 in 3 trillion, COVID may very well have been mutated in a lab experiment, InfoWars reported.
- “The presence in SARS-CoV-2 of a 19-nucleotide RNA sequence encoding an FCS at amino acid 681 of its spike protein with 100% identity to the reverse complement of a proprietary MSH3 mRNA sequence is highly unusual,” researchers said in the study.
RESEARCHERS ON COVID’S ORIGINS:
“The researchers also found genetic material from Chinese hamsters and green monkeys, which may suggest the virus was being examined in a lab, using either the animals themselves or their cells.”
BACKGROUND:
- CEO of Pfizer, Albert Bourla, recently admitted their mRNA vaccine was developed based on a lab-manufactured version of COVID rather than one that was found naturally.
- “The data we received are data that they got from what we call a pseudovirus, so it’s not the real virus,” Bourla said. “It is a virus that we have constructed in our labs and it is identical with the Omicron virus.”
- This data joins the list of evidence that contradicts NIAID Director Anthony Fauci’s original explanation of how the virus originated from bats.
